Stefania Bonaccorso

North East London NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

28h-index4.1kcitations48works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(15), Tryptophan and brain disorders(12), Bipolar Disorder and Treatment(11), Stress Responses and Cortisol(6), Forensic Toxicology and Drug Analysis(6)

Publications48 total

Pharmacogenomics to optimise psychotropic prescribing: a survey of mental health professionals’ perceptions, knowledge, and educational needs
The Pharmacogenomics Journal·2026Open Access
The future of psychiatry training in the UK – preparing for integrated care in a digital world
International Review of Psychiatry·2025
Managing Dual Diagnosis Patients and the Importance of Assessing Capacity: Data from London Inpatient Services
Brain Sciences·2025Open Access
Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and “Smart Drug” Use and Misuse
Biology·2025Open Access
Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
Brain Sciences·2025· 5 citedOpen Access
Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report
Brain Behavior & Immunity - Health·2021· 22 citedOpen Access
Psychobiological, Medical, and Psychiatric Implications of New/Novel Psychoactive Substance (NPS) Use
2020· 2 cited
Substance-Use Disorders and Violence
Comprehensive approach to psychiatry·2019· 8 cited
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
NeuroToxicology·2019· 165 citedOpen Access
Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
The British Journal of Psychiatry·2019· 33 citedOpen Access
Correction to: New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues
Current Addiction Reports·2019· 1 citedOpen Access
New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues
Current Addiction Reports·2019· 14 citedOpen Access
Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis
Psychoneuroendocrinology·2018· 55 cited
Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues
Brain Sciences·2018· 45 citedOpen Access
Cortical thickness correlates of minor neurological signs in patients with first episode psychosis
Schizophrenia Research·2018· 14 citedOpen Access
Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression
Journal of Ect·2017· 3 cited
SA1. Sexual Dysfunction and Lipid Abnormalities in First-Episode Psychosis
Schizophrenia Bulletin·2017Open Access
Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression
Journal of Ect·2017· 47 citedOpen Access
Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification
Schizophrenia Bulletin·2016· 51 citedOpen Access
Substance use, medication adherence and outcome one year following a first episode of psychosis
Schizophrenia Research·2015· 99 cited
page 1 of 3Next →

Frequent Co-authors

Robin Murray(18), Marta Di Forti(15), Valeria Mondelli(12), Paola Dazzan(11), Fabrizio Schifano(10), Anthony S. David(10), Carmine M. Pariante(9), Fiona Gaughran(9), Herbert Y. Meltzer(8), Michaël Maes(8), Tiago Reis Marques(7), A Ricciardi(7), Christos Theleritis(7), Heather Taylor(6), Anna Kolliakou(6), Amira Guirguis(6), John Corkery(6), Stefania Chiappini(5), Poonam Gardner-Sood(5), Oliver Howes(5)